Radiosensitization of human and rodent cell lines by INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radiosensitization of human and rodent cell lines by INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase

Published:2004-03 Issue:2 Volume:205 Page:155-160
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Brock William A.,Milas Luka,Bergh Sherry,Lo Ruth,Szabó Csaba,Mason Kathy A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference39 articles.

1. ADP-Ribosylation of Proteins;Althaus,1985

2. ADP-Ribose Transfer Reactions: Mechanisms and Biological Significance;Jacobson,1989

3. (ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death;Virag;J. Immunol.,1998

4. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion;Ha;Proc. Natl Acad. Sci USA,1999

5. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis;Kaufmann;Cancer Res.,1993

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PARP-1: a critical regulator in radioprotection and radiotherapy-mechanisms, challenges, and therapeutic opportunities;Frontiers in Pharmacology;2023-06-06

2. Anti-tumour and radiosensitising effects of PARP inhibitor on cervical cancer xenografts;Journal of Obstetrics and Gynaecology;2023-02-14

3. Programmed cell death in aortic aneurysm and dissection: A potential therapeutic target;Journal of Molecular and Cellular Cardiology;2022-02

4. PARP Inhibitor Olaparib Causes No Potentiation of the Bleomycin Effect in VERO Cells, Even in the Presence of Pooled ATM, DNA-PK, and LigIV Inhibitors;International Journal of Molecular Sciences;2020-11-05

5. Recent advancements in PARP inhibitors-based targeted cancer therapy;Precision Clinical Medicine;2020-08-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3